Cargando…
Coping with Viral Diversity in HIV Vaccine Design
The ability of human immunodeficiency virus type 1 (HIV-1) to develop high levels of genetic diversity, and thereby acquire mutations to escape immune pressures, contributes to the difficulties in producing a vaccine. Possibly no single HIV-1 sequence can induce sufficiently broad immunity to protec...
Autores principales: | Nickle, David C, Rolland, Morgane, Jensen, Mark A, Pond, Sergei L. Kosakovsky, Deng, Wenjie, Seligman, Mark, Heckerman, David, Mullins, James I, Jojic, Nebojsa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857809/ https://www.ncbi.nlm.nih.gov/pubmed/17465674 http://dx.doi.org/10.1371/journal.pcbi.0030075 |
Ejemplares similares
-
Comparison of Immunogen Designs That Optimize Peptide Coverage: Reply to Fischer et al
por: Nickle, David C, et al.
Publicado: (2008) -
Correction: Comparison of Immunogen Designs That Optimize Peptide Coverage: Reply to Fischer et al
por: Nickle, David C, et al.
Publicado: (2008) -
Increased Breadth and Depth of
Cytotoxic T Lymphocytes Responses against HIV-1-B
Nef by Inclusion of Epitope Variant
Sequences
por: Rolland, Morgane, et al.
Publicado: (2011) -
Recognition of HIV-1 Peptides by Host CTL Is Related to HIV-1 Similarity to Human Proteins
por: Rolland, Morgane, et al.
Publicado: (2007) -
HIV-Specific Probabilistic Models of Protein Evolution
por: Nickle, David C., et al.
Publicado: (2007)